skip to Main Content

6th Annual Risk Management and Pharmacovigilance Summit

17 – 19 September 2019 | Vienna

Pharmacovigilance is an essential element for effective use of medicines and for the public health. The aim is to minimise the risk of any harm that may come to patients and it is necessary for all PV professionals to keep pace with the new trends, regulations and requirements. The 6th Annual Risk Management and Pharmacovigilance Summit will be held in Vienna this September and as every year, it will create a great atmosphere for PV professionals to network and discuss current issues in the drug safety world. You will hear about all the necessary topics related to the new updates in regulatory, the use of Real World Data, new techniques in digital pharmacovigilance, real examples of benefit-risk evaluation and signal detection, how to go through the inspection, clinical drug safety, patient involvement and many more.

Request Full Programme Register Online
The Summit Will Start in

 SUMMIT WILL HOST SPEAKERS FROM THE WORLD’S LEADING COMPANIES

See Sample of Key Note Speakers and Their Case Studies.

Magnus
NORD

Vice President Global Patient Safety CVRM

Matthias
BÖDDING

Senior Director, Global Drug Safety Medicine

Sally
LEE

Senior Director, Epidemiology, Global Drug Safety and Risk Management

Andreas
OSANGER

Head of Clinical Drug Safety

Richard
HUGHES

Safety Science Senior Medical Director

Tina
VEIZOVIC

Senior Director, Growth & Emerging Markets, PV Affiliate Relations

EXPERIENCE BASED CASE STUDIES

One Step Ahead: From Medical Monitoring to Signal Detection in Clinical Development

Medical monitoring is the industry standard when conducting Phase 1-3 clinical trials. However, are we sure that we do not miss any safety signals?

Vifor Pharma

Role of Quality Assurance in Pharmacovigilance

Evolving PV legislations worldwide as well as an increasing number of PV inspections may trigger the foundation of a Quality Assurance Department specifically dedicated to Pharmacovigilance.

CSL Behring

Use of Real World Data in Supporting Pharmacovigilance

Real world data/evidence has become a hot topic in the pharmaceutical industry in the past decade.

Celgene Limited

HOT CONFERENCE TOPICS

Will Be Discussed

  • Use of Real World Data in Supporting Pharmacovigilance
  • Pharmacovigilance in the Emerging Markets
  • Strategic Partnerships in PV
  • Strategic Drug Safety & PhV: Learnings and Practical Considerations
  • QPPV Regulations in Non-EU Countries – Implications for Multi-/National MAH
  • From Clinical Monitoring to Signal Detection in Clinical Development
  • The Role of Quality Assurance in PV
  • Patient Involvement in Clinical Development of Medicines
  • Integrating Safety Evidence

WHAT DELEGATES SAID

About Allan Lloyds Events

 SPONSOR 2019

FOR MORE INFORMATION REQUEST FULL PROGRAMME

See what keynote speakers will be taking part in the exclusive speaking panel.
Explore what Case Studies will be discussed by our senior corporate speakers

At Allan Lloyds we understand the value of learning in groups.
Companies are therefore encouraged to avail of the below discounts:
GROUP DISCOUNT
3 or more
delegates 7%
5 or more delegates 10%
7 or more delegates 15%

THANK YOU FOR YOUR CALL REQUEST

You will be contacted shortly.

Back To Top

RELATED EVENTS

Global Medical Affairs Summit
9th Annual Pharma Marketing - Digital Marketing & CEM
9th Annual Pharma Commercial & SFE Summit
13th Annual Optimising Clinical Trials Site Selection & Feasibility Summit